Cargando…
Drug targets for corona virus: A systematic review
The 2019-novel coronavirus (nCoV) is a major source of disaster in the 21(th) century. However, the lack of specific drugs to prevent/treat an attack is a major need at this current point of time. In this regard, we conducted a systematic review to identify major druggable targets in coronavirus (Co...
Autores principales: | Prajapat, Manisha, Sarma, Phulen, Shekhar, Nishant, Avti, Pramod, Sinha, Shweta, Kaur, Hardeep, Kumar, Subodh, Bhattacharyya, Anusuya, Kumar, Harish, Bansal, Seema, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074424/ https://www.ncbi.nlm.nih.gov/pubmed/32201449 http://dx.doi.org/10.4103/ijp.IJP_115_20 |
Ejemplares similares
-
Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis
por: Bhattacharyya, Anusuya, et al.
Publicado: (2020) -
Update on the target structures of SARS-CoV-2: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
por: Chauhan, Arushi, et al.
Publicado: (2021) -
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Update on geographical variation and distribution of SARS-nCoV-2: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2021)